FOLLOW US
OnTrack Diabetes
Webinars & Podcasts

Episode 9: MannKind Corp's CCO Talks About the Benefits of Afrezza, Inhalable Insulin

MannKind Corporation is currently the only maker of inhalable insulin. Their CCO Michael Castagna, a PharmD, answers a bunch of questions about Afrezza, including how it works, why users like it, and what the concerns are around long-term side effects.

 

Afrezza inhaler

Moderator
YES! I want to listen to the FREE podcast Episode 9: MannKind Corp's CCO Talks About the Benefits of Afrezza, Inhalable Insulin – and receive tips and updates from OnTrack Diabetes.
No, thanks. Please continue without signing up for the tips.
MAIN MENU